Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.140
-0.080 (-2.48%)
May 20, 2026, 1:35 PM CST

SHE:002390 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,1541,1141,016805.98899.18624.65
Cash & Short-Term Investments
1,1541,1141,016805.98899.18624.65
Cash Growth
17.08%9.69%26.00%-10.37%43.95%-64.84%
Accounts Receivable
2,4922,4682,6913,0363,0913,082
Other Receivables
258.95263.89320.24324.63448.8600.56
Receivables
2,7512,7323,0123,3613,5403,682
Inventory
841.38901.231,0601,0011,033935.71
Prepaid Expenses
-0.080.020.030.020.02
Other Current Assets
117.6895.99164.39243.61334.34333.72
Total Current Assets
4,8644,8435,2525,4125,8065,576
Property, Plant & Equipment
2,3002,3392,4262,5182,6722,706
Long-Term Investments
402.52402.52337.47340.47343.84347.41
Goodwill
593.64593.64603.75603.75607.35607.35
Other Intangible Assets
173.82176.61189.54180.18204.37217.65
Long-Term Deferred Tax Assets
108.5110.2781.8774.1462.8155.61
Long-Term Deferred Charges
55.1958.1169.381.8497.21118.36
Other Long-Term Assets
66.616768.5735--
Total Assets
8,5648,5919,0289,2459,7949,629
Accounts Payable
724.17822.55927.97903.15977.24993.43
Accrued Expenses
15.1432.7637.1535.2732.9940.93
Short-Term Debt
264.02275.7603.54809.861,3681,390
Current Portion of Long-Term Debt
124.25103.8----
Current Portion of Leases
-2.3234.42.51-
Current Income Taxes Payable
25.9716.77.621.0917.2117.79
Current Unearned Revenue
22.0125.7725.9427.9833.2455.44
Other Current Liabilities
213.76184.37201.68256.82255.56256.6
Total Current Liabilities
1,3891,4641,8072,0592,6872,755
Long-Term Debt
1937160---
Long-Term Leases
19.7718.032121.1222.0224.81
Long-Term Unearned Revenue
19.8520.2219.5222.0418.8920.38
Long-Term Deferred Tax Liabilities
13.1613.190.730.840.56-
Other Long-Term Liabilities
0.260.280.290.310.320.34
Total Liabilities
1,4611,5532,0082,1032,7292,800
Common Stock
1,9441,9441,9441,9441,9442,027
Additional Paid-In Capital
4,4034,4034,4034,4034,4024,693
Retained Earnings
618.59569.93563.43633.34462.74354.99
Treasury Stock
-199.93-199.93-199.93-127.49--455.38
Comprehensive Income & Other
72.9372.93----
Total Common Equity
6,8396,7906,7106,8526,8086,620
Minority Interest
263.85247.95309.87289.69256.55208.74
Shareholders' Equity
7,1027,0387,0207,1427,0656,829
Total Liabilities & Equity
8,5648,5919,0289,2459,7949,629
Total Debt
427.03436.85787.55835.381,3931,415
Net Cash (Debt)
726.49677.04227.97-29.4-493.42-790.6
Net Cash Growth
297.85%196.99%----
Net Cash Per Share
0.380.360.12-0.02-0.26-0.43
Filing Date Shares Outstanding
1,8931,8961,8961,9071,9441,944
Total Common Shares Outstanding
1,8931,8961,8961,9071,9441,944
Working Capital
3,4743,3793,4453,3533,1192,822
Book Value Per Share
3.613.583.543.593.503.41
Tangible Book Value
6,0716,0205,9176,0685,9975,795
Tangible Book Value Per Share
3.213.173.123.183.082.98
Buildings
-2,7462,5172,5162,5782,396
Machinery
-1,6701,7161,7221,6971,641
Construction In Progress
-0.12145.0258.0624.9892.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.